Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The most common odontogenic tumor, arising from the epithelial component of the embryonic tooth and usually affecting the molar-ramus region of the mandible or maxilla. Although most ameloblastomas are morphologically and clinically benign, they may cause extensive local destruction, recur, or metastasize.
Biomarker and diagnostic research for ameloblastoma has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
3 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and medical devices. Pipeline includes 2 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
311 publications have been identified in PubMed for ameloblastoma. Kisho has analyzed 194 by research type. Research spans Basic Science / Preclinical (30%), Review / Meta-Analysis (22%), and Case Report / Case Series (21%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 59 |
Data assembled from 4 of 12 sources · Last updated Oct 4, 2026, 12:11 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 43 | 22% |
Patient case studies | 41 | 21% |
Disease patterns and progression | 17 | 9% |
Testing and diagnosis research | 16 | 8% |
New treatment approaches | 10 | 5% |
Clinical study results | 6 | 3% |
Other research | 2 | 1% |
Eng TY (2026). [PMID: 41391901](https://pubmed.ncbi.nlm.nih.gov/41391901/). *Semin Radiat Oncol*. [Review / Meta-Analysis]
Fonseca YG (2026). [PMID: 41109353](https://pubmed.ncbi.nlm.nih.gov/41109353/). *Mod Pathol*. [Basic Science / Preclinical]
Chang JC (2026). [PMID: 41559000](https://pubmed.ncbi.nlm.nih.gov/41559000/). *Am J Surg Pathol*. [Case Report / Case Series]
Dang ZH (2026). [PMID: 41025462](https://pubmed.ncbi.nlm.nih.gov/41025462/). *Oral Dis*. [Epidemiology / Natural History]
Lin Y (2026). [PMID: 41513503](https://pubmed.ncbi.nlm.nih.gov/41513503/). *Int J Oral Maxillofac Surg*. [Review / Meta-Analysis]
Boonsong N (2026). [PMID: 42074087](https://pubmed.ncbi.nlm.nih.gov/42074087/). *Int J Mol Sci*. [Basic Science / Preclinical]
Okechi UC (2026). [PMID: 41939128](https://pubmed.ncbi.nlm.nih.gov/41939128/). *Ann Med Surg (Lond)*. [Epidemiology / Natural History]
Zhou Y (2026). [PMID: 41980527](https://pubmed.ncbi.nlm.nih.gov/41980527/). *J Craniomaxillofac Surg*. [Review / Meta-Analysis]
Jauhiainen MK (2026). [PMID: 41960812](https://pubmed.ncbi.nlm.nih.gov/41960812/). *Eur J Oral Sci*. [Case Report / Case Series]
Devi SS (2026). [PMID: 41896974](https://pubmed.ncbi.nlm.nih.gov/41896974/). *J Med Case Rep*. [Case Report / Case Series]
AI-curated news mentioning ameloblastoma
Updated Jun 12, 2026
A recent study highlights targetable alterations in ameloblastoma, paving the way for personalized treatment strategies. This prospective observational study contributes valuable insights into precision oncology for this rare tumor type.
A case study highlights the use of staged gamma knife radiosurgery for treating multicompartment skull base metastatic ameloblastoma. This approach may offer insights into innovative treatment strategies for this rare tumor type.
A recent study published in PubMed reveals the absence of DNA viruses in ameloblastomas, suggesting a potential avenue for further research into the etiology of this rare tumor. This finding may influence future investigations into the underlying mechanisms of ameloblastoma development.